跳至主要内容
临床试验/NCT03495128
NCT03495128已完成不适用

Determination of the Time-course of Development of Insulin Resistance, and Associated Molecular and Muscular Adaptations, During Inactivity in 3 Days of Bed-rest

University of Nottingham2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2018年1月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
2
主要终点
Change in Insulin stimulated whole body glucose uptake

研究概览

简要总结

Space flight is associated with detrimental changes to the human body, including bone and muscle loss, fluid changes and deconditioning of muscles in the heart and blood vessels. Bed rest experiments, on Earth, are used to study these changes in healthy volunteers, as the disuse of muscles, and impact on the body, mimic the changes seen in the low-gravity environment of Space. Moreover, these changes are similar to those reported in people who remain in bed for long periods of time, such as is seen in intensive care or stroke patients, and bed rest studies also allow the physiological and biochemical impacts of this confinement to be investigated. For example, we know from previous research that muscle inactivity can lead to the development of resistance to the action of the hormone 'insulin', which is a longer term risk factor for the development of type 2 diabetes. Previous studies suggest that this inactivity-induced insulin resistance occurs within the first 48 hours of immobilization. However, it is not clear whether the biochemical and physiological processes underlying these short-term responses to inactivity are the same as those seen in the longer term. The current study aims to investigate the biochemical and physiological changes seen after 3 days of bed rest and to compare to those measured in a previous 57 days bed rest study carried out at Institut Médecine Physiologie Spatiale (MEDES; Toulouse, France). A 3-day period of reconditioning will subsequently be used to determine if these changes can be readily reversed.

详细描述

Bed rest is a widely accepted experimental model used to study physiological adaptations to space flight, including bone and muscle mass loss, fluid shift, and cardiovascular deconditioning. Generally, participants are asked to spend a period in bed, with all activities of daily living being performed in a horizontal or head-down tilt (HDT) position, thus minimising use of all muscles and bringing about significant physiological adaptations similar to those observed during space flight. A substantial number of human bed rest studies have been performed ranging from 3-370 days duration. However, there are currently gaps in our understanding of; the rate and magnitude of the physiological dysregulation that occurs during actual and simulated microgravity (as most studies to date have considered mainly pre and post-bed rest time-points); the sites and mechanisms controlling bed rest-induced dysregulation; whether the processes underlying acute physiological changes are the same as those seen in the longer term. Improving our understanding of these issues would enable interventions aimed at minimizing bed-rest induced physiological dysregulation to be most effectively focused on time periods when the rate of onset of physiological dysregulation is likely to be at its greatest. This would then contribute to future success being achieved in prolonged human space flight, e.g. a manned mission to Mars, because an understanding of the aetiology and time-course of the physiological dysregulation that accompanies prolonged exposure to microgravity would enable effective counter-measures to be implemented. Furthermore, bed rest models present a unique opportunity to study the consequences of bed rest on those who may sustain prolonged periods of inactivity during hospitalisation, arising from illness or injury.

Inactivity is associated with the development of insulin resistance and contributes to the development of many modern metabolic diseases including obesity, type 2 diabetes, dyslipidaemia and hypertension (1,2); with physical inactivity being cited as the principal cause of 27% of diabetes and 30% of ischaemic heart disease cases. However, the time course, relative tissue specificity (liver vs muscle) and mechanistic basis of inactivity induced insulin resistance, and its reversal by remobilisation, represent major gaps in our current understanding. Furthermore, insulin resistance is an observation with several possible aetiologies and the mechanisms involved in the development of this condition with short term bedrest/immobilisation may be different to those involved with longer term / chronic inactivity. Further research in this area is therefore warranted.

The current study is part of a larger project which includes a 60 day, long term, bed rest study conducted in collaboration with the European Space Agency, at the Institut Médecine Physiologie Spatiale facility in Toulouse, France, and will be compared to the measures being conducted in the long term bed rest experiment.

'Run-in' phase; Following a successful medical screening, participants will start a 'Run-in' phase during which their habitual activity levels will be assessed by accelerometry. Individualised energy requirements will be estimated using the modified Harris-Benedict resting metabolic rate equation and physical activity level factor and a standardised diet (macronutrient composition (expressed as a percentage of total dietary energy intake) being ~55% carbohydrates, ~30% fat and ~15% protein) will be provided for the 3-days preceding the first experimental session. The day before this session, participants will be asked to abstain from any strenuous exercise and to fast from midnight, consuming only water from that time. On arrival, a dual-energy X-ray absorptiometry (DEXA) scan will be carried out to characterise whole body and leg fat masses. The participant will then be asked to lie on a hospital bed in the supine position (one pillow) and muscle volume and architecture measurements will be determined by ultrasound imaging of the vastus lateralis muscle using a 100 mm linear array 13-4 megahertz probe. This will provide a global representation of quadriceps muscle anatomy in order to standardise calculations of leg glucose uptake and determine the contribution of muscle mass and intramyocellular lipid to leg insulin resistance. Muscle biopsy samples will be obtained from the vastus lateralis before and immediately after a 3hr hyperinsulinemic euglycemic clamp (3). Muscle biopsies will be obtained using the Bergström technique under sterile conditions, after injection of local anaesthetic. An anterograde femoral venous catheter will be inserted (using the Seldinger technique under ultrasound guidance) to enable venous blood draining from the leg to be analysed for glucose concentration and compared with the glucose concentration of arterialised-venous blood samples (Time points 0, 150, 160, 170 and 180 mins). At the same time as the femoral venous blood sample is taken, a femoral artery blood flow assessment (mmol/min) will be made using ultrasonography to enable leg glucose uptake to be calculated. Indirect calorimetry will be performed before and in the last 15 minutes of the 180min hyperinsulinaemic-euglycaemic clamp.

The day after the 'clamp' visit, a 3 Tesla magnetic resonance spectroscopy (MRS) scan will be undertaken to assess intramyocellular lipid (IMCL), extramyocellular lipid (EMCL), and hepatic triglyceride content. A magnetic resonance imaging (MRI) scan will also be performed to determine mid-thigh muscle cross-sectional area and whole body muscle mass. Following the magnetic resonance (MR) scans, participants will undergo a short lower limb proprioceptive assessment on a specially designed somatosensory apparatus called the Active Movement Extent Discrimination Assessment (AMEDA). Participants will stand on the apparatus and have each ankle moved through 5 different angles of inversion and are asked to rate the degree of ankle position. This method has been validated to determine proprioceptive discrimination and will be repeated after the MR performed on day 4 to assess differences before and after bed rest.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Physically and mentally healthy participants
  • Body mass index 20 - 26 kg/m2
  • Height 158 - 190 cm (62 - 75 inches),
  • Participants that are able to consent to participation in the entire study
  • Signed informed consent

排除标准

  • regular use of prescribed or 'over-the counter' medication
  • Bone mineral density (measured by Dual-Energy X-ray Absorptiometry) more than 1.5 standard deviation less than t-score
  • Family history of thrombosis or positive response in thrombosis blood screening: Antithrombin III, High sensitive C-Reactive Protein, protein kinase B, F-V-Leiden, Prothrombin mutation, Lupus-prothrombin time, Factor II
  • Any current medical condition
  • A medical history of thyroid dysfunction, renal function disorder (including renal stones), diabetes, cardiac arrhythmias and cardiovascular disorders, migraines, allergies, hypertension, hypocalcaemia, uric acidaemia, lipidemia or hyperhomocysteinemia, hiatus hernia, bowel surgery or gastro-oesophageal reflux
  • History of a mental health disorder
  • Smoker within six months prior to the start of the study
  • Dependence on drugs, medicine or alcohol
  • History of orthostatic intolerance, vestibular disorders or claustrophobia
  • Special food diet, vegetarian or vegan, history of intolerance to lactose or food allergy,
  • Osteosynthesis material, presence of metallic implants, history of knee problems or joint surgery/broken leg,
  • Orthopaedic or musculoskeletal disorders.

结局指标

主要结局

Change in Insulin stimulated whole body glucose uptake

时间窗: after 3 days of bed rest, compared to pre-bed rest

Determined during a hyperinsulinemic, euglycemic clamp

次要结局

  • Change in Muscle Pyruvate dehydrogenase activity(after 3 days of reconditioning, compared to post- bed rest)
  • Change in Markers of bone turnover(after 3 days of reconditioning, compared to post-bed rest)
  • Change in Insulin stimulated whole body glucose uptake(after 3 days of reconditioning, compared to post-bed rest)
  • Change in Whole body muscle mass(after 3 days of reconditioning, compared to post- bed rest)
  • Change in liver triglyceride content(after 3 days of reconditioning, compared to post-bed rest)
  • change in adipose tissue function(after 3 days of reconditioning, compared to post-bed rest)
  • Change in Insulin stimulated leg glucose uptake(after 3 days of reconditioning, compared to post- bedrest)
  • Change in Muscle gene expression(after 3 days of reconditioning, compared to post-bed rest)
  • Change in Muscle protein turnover(after 3 days of bed rest, compared to pre- bedrest)
  • Change in muscle triglyceride content(after 3 days of reconditioning, compared to post-bed rest)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elizabeth Simpson

Senior Research Fellow

University of Nottingham

研究点 (2)

Loading locations...

相似试验